Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) price on Thursday, August 01, fall -7.78% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.08.
A look at the stock’s price movement, the level at last check in today’s session was $2.25. Turning to its 52-week performance, $3.73 and $0.92 were the 52-week high and 52-week low respectively. Overall, LXRX moved 29.69% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Lexicon Pharmaceuticals Inc’s market cap currently stands at around $750.09 million.
Analysts have a consensus estimate of 2.83M for the company’s revenue for the quarter, with a low and high estimate of 1.8M and 3.4M respectively. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 24.11M, representing a 1,902.50% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that LXRX is a 100% Buy. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
LXRX’s current price about 2.32% and 11.65% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 51.71, while 7-day volatility ratio is 8.09% and 7.66% in the 30-day chart. Further, Lexicon Pharmaceuticals Inc (LXRX) has a beta value of 1.36, and an average true range (ATR) of 0.16.
If we refocus on Lexicon Pharmaceuticals Inc (NASDAQ:LXRX), historical trading data shows that trading volumes averaged 2.80 million over the past 3 months. The company’s latest data on shares outstanding shows there are 361.49 million shares.
The 2.81% of Lexicon Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 73.54% of the company’s shares. Current price change has pushed the stock 35.62% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the LXRX stock continues to rise going into the next quarter.
